2014-11-10T11:50:22-06:00 2013-12-31 520901831 ROSSLANGAN & MCKENDREE LLP 7900 WESTPARK DR STE T420 MCLEAN VA 22102 990 2013-01-01 205913680 SAFETY NET HOSPITALS FOR PHARMACEUTICAL ACCESS SAFE 2025525850 1101 15TH STREET NW NO 910 WASHINGTON DC 20005 EDWARD SLAFSKY PRESIDENT & CHIEF EXECUTIVE OFFICER 2025525850 2014-10-13 1 JEFFREY P HAYDEN P00057870 7038932660 X 2013 2015-11-30 17:44:51Z EDWARD SLAFSKY 1101 15TH STREET NW NO 910 WASHINGTON DC 20005 6058170 0 X WWW.SNHPA.ORG X 2006 DC ASSIST PROVIDERS IN THE 340B DRUG DISCOUNT PROGRAM WITH EDUCATION & ADVOCACY 15 15 24 18 1220 -18872 0 0 5209570 5949943 10018 38422 19156 50168 5238744 6038533 0 0 0 0 2176393 2763777 0 0 0 2737205 2984948 4913598 5748725 325146 289808 4270265 4215396 1826143 1410073 2444122 2805323 X THE ORGANIZATION IS THE LEADING ADVOCATE & RESOURCE FOR HEALTH CARE PROVIDERS THAT SERVE THEIR COMMUNITIES THROUGH PARTICIPATION IN THE 340B DRUG DISCOUNT PROGRAM. EVERY YEAR, THE PROGRAM HELPS MILLIONS OF UNDERSERVED AMERICANS RECEIVE DISCOUNTED...CONTINUED ON SCHEDULE O...OR FREE MEDICATIONS & LIFESAVING CLINICAL SERVICES. 0 0 EDUCATION: THE EDUCATION PROGRAM HAS THREE COMPONENTS - GENERAL EDUCATION, TECHNICAL ASSISTANCE, AND COMMUNICATION.GENERAL EDUCATION-PROVIDE EDUCATIONAL SUPPORT TO MEMBERS THROUGH WEBINARS, LOCAL ROUNDTABLES, CONFERENCES, AND ONLINE MATERIALS ON BEST PRACTICES AND GOOD STEWARDSHIP. TECHNICAL ASSISTANCE-PROVIDE ONE-ON-ONE ADVICE TO MEMBERS ON HOW TO STAY IN COMPLIANCE WITH THE 340B PROGRAM AND REMAIN UP TO DATE ON REGULATORY MATTERS.COMMUNICATION-KEEP OUR MEMBERS APRISED OF 340B NEWS AND DEVELOPMENTS THROUGH DIRECT EMAILS, ELECTRONIC BULLETINS, AND THE DRUG DISCOUNT MONITOR NEWSLETTER. ADVOCACY:ADVOCATE ON FEDERAL LEGISLATIVE AND REGULATORY ISSUES RELATED TO DRUG PRICING AND OTHER PHARMACY AND HOSPITAL MATTERS AFFECTING MEMBERS. PARTICULAR FOCUS ON ISSUES RELATED TO THE PUBLIC HEALTH SERVICE'S 340B DRUG DISCOUNT PROGRAM. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 22 0 24 1 1 1 0 0 0 0 0 X 15 15 0 0 1 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 X X THE ORGANIZATION 2025525850 1101 15TH STREET NW NO 910 WASHINGTON DC 20005 ANDREW LOWE DIRECTOR 1.00 X 0 0 0 MICHAEL BONCK DIRECTOR 1.00 X 0 0 0 BURNIS BRELAND DIRECTOR 1.00 X 0 0 0 ELLEN WILLIAMS DIRECTOR 1.00 X 0 0 0 MIKKI STIER DIRECTOR 1.00 X 0 0 0 KATIE LEBLANC DIRECTOR 1.00 X 0 0 0 BRUCE SIEGEL DIRECTOR 1.00 X 0 0 0 STEVEN PATE DIRECTOR 1.00 X 0 0 0 DONALD DAVIES DIRECTOR 1.00 X 0 0 0 CHARLES HART IMMEDIATE PAST CHAIR 1.00 X X 0 0 0 MARK BIRDWHISTELL CHAIR 1.00 X X 0 0 0 LARRY HUDSON TREASURER 1.00 X X 0 0 0 SCOTT SMITH SECRETARY 1.00 X X 0 0 0 CHARLES COOPER DIRECTOR 1.00 X 0 0 0 JAMES CHIP FALAHEE DIRECTOR 1.00 X 0 0 0 MARGARET DENNY DENARVAEZ DIRECTOR 1.00 X 0 0 0 MARY ELLA PAYNE DIRECTOR 1.00 X 0 0 0 SAM ROSS DIRECTOR 1.00 X 0 0 0 EDWARD SLAFSKY PRESIDENT AND CEO 50.00 X 341104 0 57235 MIRIAM LASAR DIRECTOR OF FINANCE AND ADMIN 40.00 X 117769 0 21066 JOHN COSTER SENIOR DIRECTOR OF GOVERNMENT RELATIONS 40.00 X 154118 0 8760 MAUREEN TESTONI GENERAL COUNSEL 40.00 X 179825 0 23920 LISA SCHOLZ COO/CHIEF PHARMACY OFFICER 40.00 X 225310 0 10255 MICHAEL HESS DIRECTOR OF OPERATIONS 40.00 X 137380 0 15581 ANNA MANGUM DIRECTOR OF PROGRAMS AND M 40.00 X 140484 0 14985 JEFFREY DAVIS ASSOCIATE COUNSEL 40.00 X 137547 0 17668 GREGORY DOGGETT ASSOCIATE COUNSEL 40.00 X 137902 0 17668 1571439 0 187138 9 0 1 0 POWERS PYLES SUTTER & VERVILLE PC 1501 M ST NW 7TH FL WASHINGTON DC 20005 LEGAL/ADVOCACY 800808 HOLLAND & KNIGHT 2099 PENNSYLVANIA AVE NW SUITE 10 WASHINGTON DC 20006 LEGAL/ADVOCACY 201576 MCALLISTER & QUINN LLC 1368 NORTH WASHINGTON AVE SCRANTON PA 18509 LOBBYING/GOVERNMENT RELATIONS 121135 MJ SIMON & COMPANY LLC 3500 TILDEN STREET NW WASHINGTON DC 20008 LOBBYING/GOVERNMENT RELATIONS 101517 4 MEMBERSHIP DUES 900099 3764912 3764912 CONFERENCE FEES & EXHI 900099 1783248 1168494 614754 CORPORATE PARTNERS 900099 271833 271833 NEWSLETTER 900099 96352 93483 1220 1649 WEBINAR AND OTHER INCO 900099 33598 21848 11750 5949943 34075 34075 23984 19637 4347 4347 4347 SUBLEASE RENTAL INCOME 900099 50168 50168 50168 6038533 5098905 1220 938408 X 1139362 1324048 38202 116850 145315 51772 40715 704969 154 705156 189383 41316 326040 137891 642783 98843 26265 19661 5748725 10691 3639444 762253 19188 171574 55816 72655 777063 284933 438875 492130 11609 2600760 105333 105333 4270265 4215396 201376 331597 1070971 547423 5913 3077 547883 527976 1826143 1410073 X 2444122 2805323 2444122 2805323 4270265 4215396 289808 114430 -43037 0 X X 0 1 X 1 0 1 0 0 363587 74044 289543 112960 44217 68743 300516 166672 133844 492130 DEFERRED RENT 520179 DEPOSIT PAYABLE 7797 527976 X 6102796 114430 114430 5988366 50167 50167 6038533 5698558 0 5698558 50167 50167 5748725 PART X, LINE 2: SNHPA IS REQUIRED TO MEASURE, RECOGNIZE, PRESENT, AND DISCLOSE IN ITS FINANCIAL STATEMENTS UNCERTAIN INCOME TAX POSITIONS SNHPA HAS TAKEN IN THE TAX YEARS THAT REMAIN SUBJECT TO EXAMINATION OR EXPECTS TO TAKE ON AN INCOME TAX RETURN. SNHPA RECOGNIZES THE TAX BENEFITS FROM UNCERTAIN INCOME TAX POSITIONS ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAX AUTHORITIES. PRIOR YEAR INCOME TAX RETURNS MAY BE SUBJECT TO AUDIT IN VARIOUS TAX JURISDICTIONS, MOST OF WHICH DEFINE OPEN TAX YEARS AS THREE YEARS FROM THE LATER OF THE DUE DATE OR THE DATE THE RETURN WAS FILED. SNHPA RECORDED NO LIABILITY FOR UNCERTAIN INCOME TAX POSITIONS FOR ANY OPEN TAX YEARS. PART XI, LINE 4B - OTHER ADJUSTMENTS: SUBLEASE RENT 50,167. PART XII, LINE 4B - OTHER ADJUSTMENTS: SUBLEASE RENT 50,167. X X X 0 0 0 EDWARD SLAFSKY PRESIDENT AND CEO 258498 0 45250 0 37356 0 17261 0 39974 0 398339 0 0 0 JOHN COSTER SENIOR DIRECTOR OF GOVERNMENT RELATI 135543 0 17000 0 1575 0 0 0 8760 0 162878 0 0 0 MAUREEN TESTONI GENERAL COUNSEL 154416 0 15000 0 10409 0 10125 0 13795 0 203745 0 0 0 LISA SCHOLZ COO/CHIEF PHARMACY OFFICER 182132 0 25000 0 18178 0 1416 0 8839 0 235565 0 0 0 MICHAEL HESS DIRECTOR OF OPERATIONS 124389 0 5400 0 7591 0 7020 0 8561 0 152961 0 0 0 ANNA MANGUM DIRECTOR OF PROGRAMS AND M 124669 0 8000 0 7815 0 6804 0 8181 0 155469 0 0 0 JEFFREY DAVIS ASSOCIATE COUNSEL 115495 0 9100 0 12952 0 6955 0 10713 0 155215 0 0 0 GREGORY DOGGETT ASSOCIATE COUNSEL 121350 0 9100 0 7452 0 6955 0 10713 0 155570 0 0 0 FORM 990, PART VI, SECTION A, LINE 4 THE ORGANIZATION AMENDED ITS BYLAWS IN 2013 TO CHANGE THE COMPOSITION AND ELECTION OF THE BOARD OF DIRECTORS, TO MAKE CHANGES TO THE STRUCTURE AND OPERATION OF BOARD COMMITTEES, AND TO MAKE ADMINISTRATIVE CHANGES. FORM 990, PART VI, SECTION A, LINE 6 FULL MEMBERS CONSIST OF HOSPITALS AND THEIR AFFILIATES THAT QUALIFY FOR OUTPATIENT DRUG DISCOUNTS UNDER SECTION 340B OF THE PUBLIC HEALTH SERVICE ACT. FORM 990, PART VI, SECTION A, LINE 7A IN ADVANCE OF THE ELECTION OF BOARD MEMBERS, THE NOMINATING COMMITTEE SOLICITS NOMINATIONS FROM FULL MEMBERS FOR ALL OF THE ELECTED DIRECTOR POSITIONS. IN THE CASE OF BOARD MEMBER VACANCIES, THE NOMINATING COMMITTEE SHALL NOMINATE ONE OR MORE PERSONS TO FILL THE POSITION AND A CANDIDATE SHALL BE APPROVED TO THE FILL THE VACANCY WHEN HE OR SHE RECEIVES A TWO-THIRDS OR GREATER VOTE OF A QUORUM OF THE BOARD. FORM 990, PART VI, SECTION B, LINE 11 THE PRESIDENT AND CEO, THE AUDIT COMMITTEE AND THE BOARD REVIEW FORM 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION ASKS THE BOARD OF DIRECTORS, OFFICERS AND ALL STAFF TO DISCLOSE ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. THEY ARE ALSO ANNUALLY ASKED TO DISCLOSE ANY RELEVANT CONFLICTS PRIOR TO EACH BOARD MEETING AND EXCUSE THEMSELVES FROM DISCUSSION OR DECISIONS THAT COULD IMPACT THEM FINANCIALLY OR WHERE THEY WOULD BE COMPROMISED. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION FOR THE EXECUTIVE DIRECTOR (NOW PRESIDENT AND CEO) WAS REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE USING NONPROFIT COMPENSATION INFORMATION PROVIDED BY THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES AND PRIOR PERFORMANCE CRITERIA. THE PRESIDENT AND CEO DETERMINES COMPENSATION FOR THE STAFF OF THE ORGANIZATION BASED ON PERFORMANCE AND COMPENSATION INFORMATION PROVIDED BY THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES. COMPENSATION FOR THE CHIEF OPERATING OFFICER/CHIEF PHARMACY OFFICER AND GENERAL COUNSEL WERE REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE USING NONPROFIT COMPENSATION INFORMATION PROVIDED BY THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES AND PRIOR PERFORMANCE CRITERIA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G OTHER FEES 705,156. PART XII, LINE 2C NEITHER THE AUDIT OVERSIGHT PROCESS NOR THE AUDIT SELECTION PROCESS CHANGED DURING THE TAX YEAR.